Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation

Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation

KRAS G12C mutations are important oncogenic mutations that confer sensitivity to direct G12C inhibitors. We retrospectively identified patients with KRAS+ NSCLC from 2015 to 2019 and assessed the imaging features of the primary tumor and the distribution of metastases of G12C NSCLC compared to those...

Full description

Bibliographic Details
Main Authors: Markus Y. Wu, Eric W. Zhang, Matthew R. Strickland, Dexter P. Mendoza, Lev Lipkin, Jochen K. Lennerz, Justin F. Gainor, Rebecca S. Heist, Subba R. Digumarthy
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
KRAS mutation
lung cancer
radiology
targeted therapy
Online Access:https://www.mdpi.com/2072-6694/13/14/3572

Internet

https://www.mdpi.com/2072-6694/13/14/3572

Similar Items